DBV Technologies
Страна
France
Краткое название
DBV Technologies
Штаб квартира
Green Square - B^atiment D 80/84 rue des Meuniers
Члены правления
Dr Pierre-Henri Benhamou, Chief Executive Officer
Mr. Bertrand Dupont, Chief Technical Officer
Mr. David Schilansky, Chief Financial Officer
Mr. Charles Ruban, Chief Development Officer
Dr Laurent Martin, Regulatory Affairs Director
Dr Wence Agbotounou, Chief Clinical Trial Officer
Mr. Bertrand Dupont, Chief Technical Officer
Mr. David Schilansky, Chief Financial Officer
Mr. Charles Ruban, Chief Development Officer
Dr Laurent Martin, Regulatory Affairs Director
Dr Wence Agbotounou, Chief Clinical Trial Officer
Разделы медицины
Аллергология и иммунология
Стадия проекта
Производство
Заболевания
Анафилактический шок
Текущие владельцы
Mr. George Horner, Board member
Dr Pierre-Henri Benhamou, CEO, Chairman and Co-Founder
Dr. Torbjorn Bjerke, Karolinska Development
Mr. Peter Hutt, Covington & Burling LLP
Dr. Rafaele Tordjman, Partner Sofinnova
Ms. Chahra Louafi, InnoBio
Mr. Didier Hoch, Chairman of BioVision (The World Life Sciences Forum)
Ms. Mailys Ferrere, Investment Director for the FSI (Fonds Strategique d’Investissement)
Dr Pierre-Henri Benhamou, CEO, Chairman and Co-Founder
Dr. Torbjorn Bjerke, Karolinska Development
Mr. Peter Hutt, Covington & Burling LLP
Dr. Rafaele Tordjman, Partner Sofinnova
Ms. Chahra Louafi, InnoBio
Mr. Didier Hoch, Chairman of BioVision (The World Life Sciences Forum)
Ms. Mailys Ferrere, Investment Director for the FSI (Fonds Strategique d’Investissement)
Технологии
Клеточные технологии, Приборы, Технологии, Фармацевтика